TLSA
Tiziana Life Sciences Ltd. Common Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
TLSA Stock Analysis: Buy, Sell, or Hold?
$0.62
+0.01 (+1.77%)
▲
5d:
-2.66%
30d:
-43.03%
90d:
-40.29%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
55/100
Position
OVERSOLD
30-Day Fair Range
$0.73 – $1.10
Position: OVERSOLD
Forward P/E & Valuation
-4.6x
Next 12M consensus est.
Wall Street Target
$7.96
+1181.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.57 / $0.95
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: TLSA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When TLSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TLSA is currently trading at $0.62, which is considered oversold relative to its 30-day fair value range of $0.73 to $1.10.
Technical Outlook: Technically, TLSA is in a downtrend. Immediate support is located at $0.57, while resistance sits at $0.95.
Market Sentiment: TLSA scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.96 (+1181.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TLSA is in a downtrend. Immediate support is located at $0.57, while resistance sits at $0.95.
Market Sentiment: TLSA scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.96 (+1181.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.73 -
$1.10
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$0.73 -
$1.10
Current vs Trading Range
OVERSOLD
Support Level
$0.57
Resistance Level
$0.95
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1181.6% below Wall St target ($7.96)
- CAUTION: Bottoming setup, but lagging the sector by 31% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-4.57
Wall Street Target
$7.96
(+1181.6%)
Share TLSA Analysis
Share this live TLSA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TLSA)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses optimism about $TLSA, aiming to increase ownership before potential Orphan Drug designation for MSA. No recent Yahoo Finance news is available for analysis.
Key Retail Themes:
Bullish sentiment towards $TLSA
Anticipation of potential Orphan Drug designation for MSA
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 10:00 PM ET
Data refreshes hourly during market hours. Next update: 11:00 PM
Data refreshes hourly during market hours. Next update: 11:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLSA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 43 HOLD |
|
PTGX
Protagonist Therapeutics… |
STRONG BUY
14 analysts |
$182 | 47 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 32 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TLSA Research Pages
